Cost Analysis of High-Flow Oxygen Therapy Compared with Conventional Oxygen Therapy in Severe COVID-19 in Colombia: Data from a Randomized Clinical Trial.

ABSTRACT:

Background

A randomized clinical trial (HiFlo-COVID-19 Trial) showed that among patients with severe COVID-19, treatment with high-flow oxygen therapy (HFOT) significantly reduced the need for invasive mechanical ventilation support and time for clinical recovery compared with conventional oxygen therapy (COT). However, the cost of this strategy is unknown.

Objective

We examined total cost of HFOT treatment compared with COT in real-world setting.

Methods

We conducted a post-trial-based cost analysis from the perspective of a managed competition healthcare system, using actual records of billed costs. Cost categories include general ward, intensive care unit, procedures, imaging, laboratories, medications, supplies, and others.

Results

A total of 188 participan

SUBMITTER: Prada SI 

PROVIDER: S-EPMC10564115 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature